Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks

Srpski Arhiv za Celokupno Lekarstvo

Volumn 140, Issue 9-10, 2012, Pages 606-611

  Karadžov Orlić, Nataša ^a   Egić, Amira ^a   Filimonović, Dejan ^a   Marinković, Maja ^a   Damnjanović Pažin, Barbara ^a   Milovanović, Zagorka ^a   Joksić, Ivana ^a   Branković, Snežana ^b   Lukić, Relja ^a   Mandić, Vesna ^a   Cerović, Nikola ^a   Mojović, Donka ^a   Plamenac, Sanja ^a   Stanković, Minja ^a   Maglić, Dragana ^a   Miković, Željko ^a  

^a University Clinic for Obstetrics and Gynecology Narodni Front   (Serbia)

^b INSTITUTE OF MENTAL HEALTH   (Serbia)

Author keywords

Aneuploidies; First trimester screening; Nuchal translucence

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ANEUPLOIDY; ARTICLE; BLOOD; CHROMOSOME DISORDER; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRENATAL DIAGNOSIS; TRISOMY;

ANEUPLOIDY; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOME DISORDERS; FEMALE; HUMANS; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; TRISOMY; ULTRASONOGRAPHY, PRENATAL;

EID: 84872231204     PISSN: 03708179     EISSN: None     Source Type: Journal    
DOI: 10.2298/SARH1210606K     Document Type: Article

References (15)

1. Nicolaides K. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn. 2011;31:7-15.
2. Nicolaides K, Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol. 2005;25:221-6.
3. Spencer K, Souter V, Tul N. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta human chorionic gonadotropin and pregnancy-associated plasma protein A. Ultrasound Obstet Gynecol. 1999;13:231-7.
4. Spencer K, Spencer CE, Power M. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. Br J Obstet Gynecol. 2000;107:1271-5.
5. Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta hCG and pregnancy-associated plasma protein A. Hum. Reprod. 2008a; 23(9):1968-75.
6. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: John Wiley & Sons, Inc.; 2000. p. 156-164.
7. Nicolaides KH. Screening for chromosomal defects. Ultrasound Obstet Gynecol. 2003;21:313-21.
8. Nicolaides KH. The 11-13+6 weeks scan. London: Fetal Medicine Foundation; 2004.
9. Hyett JA, Perdu M, Sharland G, Snijeders R, Nicolaides KH. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ. 1999;318:81-5.
10. Sonek JD, Glover M, Zhou M, Nicolaides KH. First trimester ultrasound screening: an update. Donald School J Ultrasound Obstet Gynecol. 2010;4(2):97-116.
11. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. Firsttrimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol. 2008b; 31:493-502.
12. Wright D, Spencer K, Kagan K, Torring N, Petersen O. B, Christou A. First-trimester combined screening for trisomy 21 at 7-14 weeks gestation. Ultrasound Obstet Gynecol. 2010;36:104-411.
13. Trninić-Pjević A, Novakov-Mikić A. First trimester ultrasound screening of chromosomal abnormalities. Srp Arh Celok Lek. 2007;135(3-4):153-6.
14. Novakov-Mikić A, Potić Z, Pjević A. Ultrasound screening program for chromosomal abnormalities - the first 2000 women. Med Pregl. 2007;60(1-2):66-70.
15. Karadzov-Orlic N, Egic A, Milovanovic Z, Marinkovic M, Damnjanovic-Pazin B, Lukic R, et al. Improved diagnostic accuracy by using secondary ultrasound markers in the first-trimester screening for trisomies 21, 18and 13 and Turner syndrome. Prenatal Diagnosis. 2012;32:638-43.